Associations of Cataract with Antioxidant Enzymes and Other Risk Factors: The French Age-Related Eye Diseases (POLA) Prospective Study

Ophthalmology

Volumn 110, Issue 12, 2003, Pages 2318-2326

  Delcourt, Cécile ^a   Carrière, Isabelle ^a   Delage, Martine ^b   Descomps, Bernard ^b   Cristol, Jean Paul ^b   Papoz, Laure ^b  

^a INSERM   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CATARACT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; FRANCE; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SLIT LAMP; SMOKING;

EID: 0344011578     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00713-9     Document Type: Article

References (49)

1. Javitt JC, Wang F, West SK. Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health 1996;17:159-77.
2. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993;111:1041-9.
3. Babizhayev MA. Failure to withstand oxidative stress induced by phospholipid hydroperoxides as a possible cause of the lens opacities in systemic diseases and ageing. Biochim Biophys Acta 1996;1315:87-99.
4. Bunce GE, Hess JL. Biochemical changes associated with selenite-induced cataract in the rat. Exp Eye Res 1981;33:505-14.
5. Boscia F, Grattagliano I, Vendemiale G, et al. Protein oxidation and lens opacity in humans. Invest Ophthalmol Vis Sci 2000;41:2461-5.
6. Christen WG Jr. Antioxidants and eye disease. Am J Med 1994;97:14S-17S.
7. Delcourt C, Cristol JP, Leger CL, et al. Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Âge. Ophthalmology 1999;106:215-22.
8. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration: The POLA study. Pathologies Oculaires Liées à I'Âge. Arch Ophthalmol 1998; 116:1031-5.
9. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol 1993;111:831-6.
10. Delcourt C, Cristol JP, Tessier F, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA Study. Pathologies Oculaires Liées à l'Âge. Am J Epidemiol 2000;151:497-504.
11. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60.
12. Casado A, de La Torre R, Lopez-Fernandez E. Antioxidant enzyme levels in red blood cells from cataract patients. Gerontology 2001;47:186-8.
13. Jacques PF, Chylack LT Jr, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337-40.
14. Kosenko EA, Kaminsky YG, Stavrovskaya IG, et al. The stimulatory effect of negative air ions and hydrogen peroxide on the activity of superoxide dismutase. FEBS Lett 1997;410:309-12.
15. Niwa Y, Ishimoto K, Kanoh T. Induction of superoxide dismutase in leukocytes by paraquat: correlation with age and possible predictor of longevity. Blood 1990;76:835-41.
16. Rohrdanz E, Schmuck G, Ohler S, Kahl R. The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. Brain Res 2001;900:128-36.
17. Yoo HY, Chang MS, Rho HM. The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem 1999;274:23887-92.
18. Khanna P, Wang L, Ansari NH. Semi-quantitation of mRNA by polymerase chain reaction. Levels of oxidative defense enzymes and aldose reductase in rat lenses cultured in hyperglycemic or oxidative medium. Res Commun Mol Pathol Pharmacol 1996;92:3-18.
19. Tumminia SJ, Chambers C, Qin C, et al. A comparison of antioxidant enzyme activities in organ-cultured rhesus monkey lenses following peroxide challenge. Curr Eye Res 1996;15:845-51.
20. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J 1995;9:1173-82.
21. Mohan M, Sperduto RD, Angra SK, et al. India-US case-control study of age-related cataracts. India-US Case-Control Study Group. Arch Ophthalmol 1989;107:670-6.
22. Leske MC, Wu SY, Hyman L, et al. Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group. Arch Ophthalmol 1995;113:1113-9.
23. Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 1991;133:541-53.
24. Carper D, John M, Chen Z, et al. Gene expression analysis of an H(2)O(2)-resistant lens epithelial cell line. Free Radic Biol Med 2001;31:90-7.
25. Spector A, Kuszak JR, Ma W, Wang RR. The effect of aging on glutathione peroxidase-i knockout mice-resistance of the lens to oxidative stress. Exp Eye Res 2001;72:533-45.
26. Maddipati KR, Marnett LJ. Characterization of the major hydroperoxide-reducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem 1987;262:17398-403.
27. Martin-Alonso JM, Ghosh S, Coca-Prados M. Cloning of the bovine plasma selenium-dependent glutathione peroxidase (GP) cDNA from the ocular ciliary epithelium: expression of the plasma and cellular forms within the mammalian eye. J Biochem (Tokyo) 1993;114:284-91.
28. Haung W, Koralewska-Makar A, Bauer B, Akesson B, Extracellular glutathione peroxidase and ascorbic acid in aqueous humor and serum of patients operated on for cataract. Clin Chim Acta 1997;261:117-30.
29. Chu FF, Esworthy RS, Doroshow JH, et al. Expression of plasma glutathione peroxidase in human liver in addition to kidney, heart, lung, and breast in humans and rodents. Blood 1992;79:3233-8.
30. Taylor HR. Epidemiology of age-related cataract. Eye 1999;13(Pt 3b):445-8.
31. Ross MA, Crosley LK, Brown KM, et al. Plasma concentrations of carotenoids and antioxidant vitamins in Scottish males: influences of smoking. Eur J Clin Nutr 1995;49:861-5.
32. Ramakrishnan S, Sulochana KN, Selvaraj T, et al. Smoking of beedies and cataract: cadmium and vitamin C in the lens and blood. Br J Ophthalmol 1995;79:202-6.
33. Cekic O. Effect of cigarette smoking on copper, lead, and cadmium accumulation in human lens. Br J Ophthalmol 1998;82:186-8.
34. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991;109:244-51.
35. Miglior S, Marighi PE, Musicco M, et al. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalmic Epidemiol 1994;1:93-105.
36. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:8-14.
37. Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998;280:539-43.
38. Klein BE, Klein R, Lee KE. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: the Beaver Dam Eye Study. Am J Ophthalmol 1997;123:338-46.
39. Leske MC, Chylack LT Jr, He Q, et al. Risk factors for nuclear opalescence in a longitudinal study. LSC Group. Longitudinal Study of Cataract. Am J Epidemiol 1998;147:36-41.
40. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 1998;126:782-90.
41. Leske MC, Wu SY, Hennis A, et al. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 1999;106:35-41.
42. Schaumberg DA, Glynn RJ, Christen WG, et al. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr 2000;72:1495-502.
43. Hiller R, Podgor MJ, Sperduto RD, et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998;105:1244-50.
44. West S, Munoz B, Schein OD, et al. Cigarette smoking and risk for progression of nuclear opacities. Arch Ophthalmol 1995;113:1377-80.
45. Leske MC, Connell AM, Wu SY, et al. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol 2001;119:89-95.
46. Karbassi M, Khu PM, Singer DM, Chylack LT Jr. Evaluation of lens opacities classification system III applied at the slit-lamp. Optom Vis Sci 1993;70:923-8.
47. Leske MC, Chylack LT, He QM, et al. Incidence and progression of cortical and posterior subcapsular opacities: the Longitudinal Study of Cataract. The LSC Group. Ophthalmology 1997;104:1987-93.
48. Leske MC, Chylack LT Jr, Wu SY, et al. Incidence and progression of nuclear opacities in the Longitudinal Study of Cataract. Ophthalmology 1996;103:705-12.
49. Klein BE, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol 1998;116:219-25.